Singapore markets closed

scPharmaceuticals Inc. (2SX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.5200-0.0400 (-0.88%)
As of 09:02AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
13,593
13,593
0
0
0
Cost of revenue
3,811
3,811
0
-
-
Gross profit
9,782
9,782
0
-
-
Operating expenses
Research development
11,809
11,809
15,533
16,039
18,149
Selling general and administrative
53,369
53,369
20,624
9,784
11,784
Total operating expenses
65,178
65,178
36,157
25,823
29,933
Operating income or loss
-55,396
-55,396
-36,157
-25,823
-29,933
Interest expense
8,123
8,123
3,302
2,575
2,587
Total other income/expenses net
3,605
3,605
1,418
315
-4
Income before tax
-54,810
-54,810
-36,838
-28,034
-32,209
Income from continuing operations
-54,810
-54,810
-36,838
-28,034
-32,209
Net income
-54,810
-54,810
-36,838
-28,034
-32,209
Net income available to common shareholders
-54,810
-54,810
-36,838
-28,034
-32,209
Basic EPS
-1.36
-1.42
-1.30
-1.02
-1.31
Diluted EPS
-1.36
-1.42
-1.30
-1.02
-1.31
Basic average shares
36,638
38,514
28,359
27,352
24,569
Diluted average shares
36,638
38,514
28,359
27,352
24,569